Daré Bioscience (DARE) Short Interest Ratio & Short Volume → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free DARE Stock Alerts $0.43 +0.07 (+19.19%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Daré Bioscience Short Interest DataCurrent Short Volume290,300 sharesPrevious Short Volume246,900 sharesChange Vs. Previous Month+17.58%Dollar Volume Sold Short$89,267.25Short Interest Ratio / Days to Cover0.4Last Record DateApril 30, 2024Outstanding Shares100,580,000 sharesPercentage of Shares Shorted0.29%Today's Trading Volume917,097 sharesAverage Trading Volume578,548 sharesToday's Volume Vs. Average159% Short Selling Daré Bioscience ? Sign up to receive the latest short interest report for Daré Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDARE Short Interest Over TimeDARE Days to Cover Over TimeDARE Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Daré Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024290,300 shares $89,267.25 +17.6%N/A0.4 $0.31 4/15/2024246,900 shares $118,536.69 +5.1%N/A0.6 $0.48 3/31/2024235,000 shares $115,197.00 -48.5%N/A0.6 $0.49 3/15/2024456,200 shares $213,684.08 -14.0%N/A1.1 $0.47 2/29/2024530,500 shares $304,507.00 +5.2%N/A0.8 $0.57 2/15/2024504,200 shares $184,385.94 -10.1%N/A0.8 $0.37 Get the Latest News and Ratings for DARE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Daré Bioscience and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024560,900 shares $182,292.50 -11.3%N/A1 $0.33 1/15/2024632,000 shares $229,795.20 -27.3%N/A1.1 $0.36 12/31/2023869,800 shares $268,768.20 -11.2%N/A1.6 $0.31 12/15/2023979,200 shares $344,580.48 +76.8%N/A2 $0.35 11/30/2023553,900 shares $193,865.00 +23.9%N/A1.3 $0.35 11/15/2023447,000 shares $152,963.40 -22.6%N/A1.8 $0.34 10/31/2023577,300 shares $247,084.40 +0.9%N/A2.5 $0.43 10/15/2023572,300 shares $263,258.00 -4.7%N/A2.4 $0.46 9/30/2023600,300 shares $277,218.54 +4.8%N/A2.2 $0.46 9/15/2023572,800 shares $292,128.00 -31.6%N/A1.9 $0.51 8/31/2023836,800 shares $572,622.24 +19.4%N/A2.7 $0.68 8/15/2023700,900 shares $515,091.41 +11.6%N/A2.4 $0.73 7/31/2023628,300 shares $469,151.61 -9.3%N/A2.2 $0.75 7/15/2023692,400 shares $602,388.00 +45.1%N/A2.6 $0.87 6/30/2023477,100 shares $434,208.71 +29.4%N/A2.2 $0.91 6/15/2023368,600 shares $353,856.00 +7.6%N/A1.9 $0.96 5/31/2023342,600 shares $346,026.00 -9.5%N/A1.8 $1.01 5/15/2023378,600 shares $382,386.00 -25.9%N/A2 $1.01 4/30/2023511,000 shares $511,000.00 -16.6%N/A2.5 $1.00 4/15/2023612,400 shares $618,524.00 +12.5%N/A2.2 $1.01 3/31/2023544,400 shares $566,176.00 +16.8%N/A1.8 $1.04 3/15/2023466,000 shares $466,000.00 -15.9%N/A1.5 $1.00 2/28/2023554,100 shares $576,264.00 -49.6%N/A1.8 $1.04 2/15/20231,100,000 shares $1.24 million -38.6%N/A3.5 $1.13 1/31/20231,790,000 shares $2.27 million +51.7%N/A5.7 $1.27 1/15/20231,180,000 shares $1.42 million -13.2%N/A5.1 $1.20 12/30/20221,360,000 shares $1.13 million +33.3%N/A5.7 $0.83 12/15/20221,020,000 shares $922,080.00 -12.8%N/A4.1 $0.90 11/30/20221,170,000 shares $1.04 million +4.5%N/A4.5 $0.89 11/15/20221,120,000 shares $1.06 million -0.9%N/A4.1 $0.95 10/31/20221,130,000 shares $1.10 million -8.1%N/A3.8 $0.97 10/15/20221,230,000 shares $1.10 million -12.1%N/A3.7 $0.89 9/30/20221,400,000 shares $1.40 million -0.7%N/A3.6 $1.00 9/15/20221,410,000 shares $1.55 million -3.4%N/A2.2 $1.10Obama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here DARE Short Interest - Frequently Asked Questions What is Daré Bioscience's current short interest? Short interest is the volume of Daré Bioscience shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 290,300 shares of DARE short. Learn More on Daré Bioscience's current short interest. Which institutional investors are shorting Daré Bioscience? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Daré Bioscience: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Daré Bioscience's short interest increasing or decreasing? Daré Bioscience saw a increase in short interest in April. As of April 30th, there was short interest totaling 290,300 shares, an increase of 17.6% from the previous total of 246,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Daré Bioscience's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Daré Bioscience: Apollomics, Inc. (0.19%), ImmunoPrecise Antibodies Ltd. (1.45%), Viracta Therapeutics, Inc. (2.54%), Aprea Therapeutics, Inc. (1.90%), Acurx Pharmaceuticals, Inc. (4.67%), Theratechnologies Inc. (0.10%), NRx Pharmaceuticals, Inc. (6.36%), BriaCell Therapeutics Corp. (4.76%), Fortress Biotech, Inc. (12.69%), Spruce Biosciences, Inc. (0.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Daré Bioscience stock? Short selling DARE is an investing strategy that aims to generate trading profit from Daré Bioscience as its price is falling. DARE shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Daré Bioscience? A short squeeze for Daré Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DARE, which in turn drives the price of the stock up even further. How often is Daré Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DARE, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: APLM Short Squeeze IPA Short Squeeze VIRX Short Squeeze APRE Short Squeeze ACXP Short Squeeze THTX Short Squeeze NRXP Short Squeeze BCTX Short Squeeze FBIO Short Squeeze SPRB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DARE) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe 1,000X Crypto PlaybookTrue Market InsidersGold Set to EXPLODE!Gold Safe ExchangeCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMost important medical advance in 100 yearsThe Oxford ClubBill Clinton Backing Biden Replacement???The Freeport SocietyCharles Payne Demystifies OptionsUnstoppable Prosperity